Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2020-03-13 Purchase | 2020-03-17 4:51 pm | Aimmune Therapeutics Inc. | AIMT | Oxtoby Andrew Chief Commercial Officer | 3,000 | $14.76 | $44,266 | 25,015 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2023-08-11 Disposition | 2023-08-11 4:11 pm | N/A 2033-02-27 | CHINOOK THERAPEUTICS INC. | KDNY | Oxtoby Andrew Chief Commercial Officer | 160,000 | $18.18 | 0 (Direct) | View |
| 2023-08-11 Disposition | 2023-08-11 4:11 pm | N/A N/A | CHINOOK THERAPEUTICS INC. | KDNY | Oxtoby Andrew Chief Commercial Officer | 40,000 | $0 | 0 (Direct) | View |
| 2023-02-28 Option Award | 2023-03-02 5:00 pm | N/A 2033-02-27 | CHINOOK THERAPEUTICS INC. | KDNY | Oxtoby Andrew Chief Commercial Officer | 200,000 | $0 | 200,000 (Direct) | View |
| 2020-10-13 Disposition | 2020-10-14 4:15 pm | N/A N/A | Aimmune Therapeutics Inc. | AIMT | Oxtoby Andrew Chief Commercial Officer | 67,500 | $10.69 | 0 (Direct) | View |
| 2020-10-10 Equity Swap | 2020-10-14 4:15 pm | N/A N/A | Aimmune Therapeutics Inc. | AIMT | Oxtoby Andrew Chief Commercial Officer | 6,345 | $34.5 | 0 (Direct) | View |
| 2020-10-13 Disposition | 2020-10-14 4:15 pm | N/A N/A | Aimmune Therapeutics Inc. | AIMT | Oxtoby Andrew Chief Commercial Officer | 150,000 | $12.56 | 0 (Direct) | View |
| 2020-10-13 Disposition | 2020-10-14 4:15 pm | N/A N/A | Aimmune Therapeutics Inc. | AIMT | Oxtoby Andrew Chief Commercial Officer | 20,250 | $34.5 | 0 (Direct) | View |
| 2020-09-15 Tax Withholding | 2020-09-16 5:19 pm | N/A N/A | Aimmune Therapeutics Inc. | AIMT | Oxtoby Andrew Chief Commercial Officer | 840 | $34.25 | 26,595 (Direct) | View |
| 2020-05-10 Option Award | 2020-05-12 5:20 pm | N/A N/A | Aimmune Therapeutics Inc. | AIMT | Oxtoby Andrew Chief Commercial Officer | 2,420 | $0 | 27,435 (Direct) | View |
| 2020-02-28 Option Award(A) | 2020-03-04 9:53 pm | N/A 2030-02-28 | Aimmune Therapeutics Inc. | AIMT | Oxtoby Andrew Chief Commercial Officer | 78,750 | $0 | 89,515 (Direct) | View |
| 2020-01-22 Tax Withholding | 2020-03-04 9:49 pm | N/A N/A | Aimmune Therapeutics Inc. | AIMT | Oxtoby Andrew Chief Commercial Officer | 1,235 | $33.23 | 10,765 (Direct) | View |
| 2020-02-28 Option Award | 2020-03-03 8:35 pm | N/A 2030-02-28 | Aimmune Therapeutics Inc. | AIMT | Oxtoby Andrew Chief Commercial Officer | 78,750 | $0 | 90,750 (Direct) | View |